Open main menu

Psychiatrienet β

Changes

Combining-Valproic acid-Risperidone

472 bytes removed, 12:28, 23 April 2010
no edit summary
| base = valproic acid
| add = risperidone
| info = * Valproic acid is principally metabolized by CYP2C9, CYP2C19, CYP2A6 and UDP-glucuronosyltransferases. Valproic acid is an inhibitor of the enzymes CYP2C9, epoxide-hydroxylase and UDP-glucuronosyltransferases. * Risperidone is principally metabolized by CYP2D6 to an active metabolite. * This combination of drugs may have possible synergistic effects. However, this combination will also have additive side effects. Dose adaptation will be recommended for this combination. 
| start =
* Coadministration with risperidone may alter the serum concentrations of valproic acid, although data are conflicting.
Bureaucrats, checkuser, developer, editor, reviewer, Administrators, widgeteditor
1,951
edits